Why does ADHD matter in primary care? Dr. Peter Mason explains the real-world impact of under-recognised ADHD and why addressing it can improve outcomes for both the patient and the service provider.

A practical, primary-care guide to post-diagnostic ADHD management aligned to NICE guidance. Covers medication and non-medication options for adults and children, plus common concerns and side effects. Concludes with how shared care works in practice (monitoring in primary care with specialist review).

A concise, case-led overview of best-practice shared care for ADHD, focused on what “good” looks like in day-to-day primary care. Highlights why shared care matters, how it benefits patients and services, and how to manage common real-world problems.

In this expert-led session, Jesper Andreasen, Associate Professor of Drug Design and Pharmacology at the University of Copenhagen, explores the neurobiology and pharmacology underpinning stimulant treatments for ADHD.  The presentation reviews the roles of dopamine and noradrenaline in ADHD, explains how stimulant medications work, and highlights key differences between amphetamine-based treatments and methylphenidate preparations.

In this expert-led session, Dr Alessandra Cappai explores the impact of comorbid depression in adults with ADHD, highlighting diagnostic challenges and practical considerations for management.

In this expert-led session, Dr Kobus van Rensburg examines the complexities of co-occurring ADHD and autism, discussing symptom overlap, assessment challenges, and considerations for personalised care.

In this expert-led session, Dr. Anneka Tomlinson explores the complex relationship between ADHD and substance use disorder in adults, highlighting key diagnostic challenges and practical considerations for assessment and management.